ILMN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Illumina Inc's research and development for the three months ended in Dec. 2016 was $130 Mil. Its research and development for the trailing twelve months (TTM) ended in Dec. 2016 was $504 Mil.
This is the expense the company spent on research and development.
Illumina Inc Research & Development for the trailing twelve months (TTM) ended in Dec. 2016 was 123.994 (Mar. 2016 ) + 124.589 (Jun. 2016 ) + 125.917 (Sep. 2016 ) + 129.915 (Dec. 2016 ) = $504 Mil.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Illumina Inc Annual Data
|Research & Development||74||100||141||178||197||231||277||388||402||504|
Illumina Inc Quarterly Data
|Research & Development||85||143||92||96||99||114||124||125||126||130|